Kioxia Corporation today announced the KIOXIA XG10 Series solid state drives (SSDs), its latest high-performance client storage solution engineered for PC OEMs. Targeting the performance segment, the new KIOXIA XG10 Series leverages PCIe® 5.0 technology to significantly elevate speed and responsiveness across data-intensive client applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513852514/en/KIOXIA XG10 Series Client ...

Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous use, the first and only approved biosimilar to PERJETA (pertuzumab) in Europe, for all indications of the reference product.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429686426/en/ “As the first, and currently the o...

LMR Naturals by IFF — a global leader in natural ingredients for perfumery, cosmetics and flavors — will debut its latest innovations at the International Exhibition of Raw Materials for Perfumery (SIMPPAR), May 26–27 in Grasse. During the industry event, IFF will unveil new additions to its LMR Hearts collection, highlighting its naturals expertise and pioneering science. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260506065669/...

Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that it has been selected by Criteo, the global commerce intelligence platform, to modernize its global travel program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507251188/en/Global commerce intelligence platform delivers high employee satisfaction with Navan Criteo set out to provide its global workforce with an easy-to-use tra...

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to a supplemental Biologics License Application (sBLA) for TEVIMBRA® (tislelizumab) in combination with ZIIHERA® (zanidatamab) and chemotherapy for the first-line treatment of unresectable locally advanced/metastatic HER2-positive (HER2) gastric, gastroesophageal junction, or esophageal adenocarcinoma. The FDA has a...

The latest research from Omdia shows that US PC shipments (excluding tablets) grew 3% year-on-year in Q4 2025 to 18.2 million units, reversing two consecutive quarters of annual decline. The return to growth was driven by a combination of the peak of Windows 11 commercial refreshes, holiday-season demand, and vendor efforts to secure inventory ahead of anticipated memory and storage supply constraints in 2026. Full-year 2025 shipments reached 71.5 million units, up 3% from 2024, but 2026 shipme...